2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Streeter Jennifer | — | 500,000 | Jun 14, 2023 |
| Cavanagh William | Chief R&D Officer | 475,000 | Aug 1, 2022 |
| Girard Roger | CEO | 371,034 | Nov 13, 2007 |
| Swanberg David | EVP Operations & Secretary | 329,409 | Feb 19, 2008 |
| Babcock Dwight William | CEO | 326,402 | Nov 13, 2015 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4, 2026 | Martinez Maria E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 2, 2026 | Mar 4, 2026 | Morich Frank | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 2, 2026 | Mar 4, 2026 | Williamson Robert F III | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 2, 2026 | Mar 4, 2026 | HENSON HEIDI | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 2, 2026 | Mar 4, 2026 | Woods Lori A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 2, 2026 | Mar 4, 2026 | Spoor Johan M. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 2, 2026 | Mar 4, 2026 | Hunt Jonathan Robert | Chief Accounting Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 2, 2026 | Mar 4, 2026 | Puhlmann Markus | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 13, 2025 | Nov 17, 2025 | Hunt Jonathan Robert | Chief Accounting Officer | Buy | 91.3 | +11,000 | 22.54% | ✗ | $22.3K |
| Nov 12, 2025 | Nov 14, 2025 | Williamson Robert F III | Director | Buy | 86.3 | +9,498 | 8.69% | ✗ | $19.9K |
| Sep 4, 2025 | Sep 5, 2025 | Sendek Joel | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 5, 2025 | Sendek Joel | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 3, 2025 | Sep 5, 2025 | Martinez Maria E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 5, 2025 | Martinez Maria E | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 28, 2025 | Apr 1, 2025 | Spoor Johan M. | CEO | Buy | 95.0 | +26,676 | 43.73% | ✗ | $59.7K |
| Mar 28, 2025 | Apr 1, 2025 | Williamson Robert F III | Director | Buy | 95.0 | +60,337 | 123.11% | ✗ | $132.2K |
| Mar 28, 2025 | Apr 1, 2025 | Graham Juan | CFO | Buy | 95.0 | +33,333 | 1649.33% | ✗ | $74.9K |
| Mar 31, 2025 | Apr 1, 2025 | Woods Lori A | Director | Buy | 91.3 | +23,475 | 14.25% | ✗ | $50K |
| Mar 3, 2025 | Mar 5, 2025 | Puhlmann Markus | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 3, 2025 | Mar 5, 2025 | Hunt Jonathan Robert | Chief Accounting Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 3, 2025 | Mar 5, 2025 | Spoor Johan M. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 3, 2025 | Mar 5, 2025 | HENSON HEIDI | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 3, 2025 | Mar 5, 2025 | Williamson Robert F III | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 3, 2025 | Mar 5, 2025 | Morich Frank | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 3, 2025 | Mar 5, 2025 | Woods Lori A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 6, 2025 | Jan 7, 2025 | Graham Juan | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 7, 2025 | Graham Juan | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 4, 2024 | Dec 6, 2024 | HENSON HEIDI | Director | Buy | 95.0 | +25,975 | 100.00% | ✗ | $100K |
| Dec 4, 2024 | Dec 4, 2024 | Spoor Johan M. | CEO | Buy | 91.3 | +8,000 | 16.93% | ✗ | $30.1K |
| Dec 4, 2024 | Williamson Robert F III | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 4, 2024 | Spoor Johan M. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 25, 2024 | Nov 27, 2024 | Williamson Robert F III | Director | Buy | 78.8 | +6,266 | 1.47% | ✗ | $22.8K |
| Nov 25, 2024 | Nov 27, 2024 | Hunt Jonathan Robert | CFO | Buy | 91.3 | +12,829 | 35.66% | ✗ | $49K |
| Nov 25, 2024 | Nov 26, 2024 | Spoor Johan M. | CEO | Buy | 95.0 | +26,500 | 12.77% | ✗ | $100.5K |
| Jul 17, 2024 | Jul 19, 2024 | Austin Mark John | VP Finance/Prin Fin&Acct Offic | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 24, 2024 | Williamson Robert F III | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 24, 2024 | Morich Frank | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 24, 2024 | Woods Lori A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 24, 2024 | HENSON HEIDI | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 24, 2024 | Spoor Johan M. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 24, 2024 | Puhlmann Markus | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2024 | Jun 24, 2024 | Hunt Jonathan Robert | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 17, 2024 | Jun 18, 2024 | Hunt Jonathan Robert | CFO | Buy | 86.3 | +1,800 | 5.27% | ✗ | $17.7K |
| Jun 14, 2024 | Jun 18, 2024 | Woods Lori A | Director | Buy | 83.8 | +4,587 | 2.86% | ✗ | $50K |
| Jun 13, 2024 | Jun 13, 2024 | Spoor Johan M. | CEO | Buy | 95.0 | +100,000 | 92.96% | ✗ | $117.4K |
| Jun 5, 2024 | Woods Lori A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 3, 2024 | Jun 4, 2024 | Woods Lori A | Director | Buy | 78.8 | +34,246 | 2.25% | ✗ | $50K |
| May 31, 2024 | Jun 3, 2024 | Hunt Jonathan Robert | CFO | Buy | 86.3 | +25,006 | 7.90% | ✗ | $35K |
| May 31, 2024 | Jun 3, 2024 | Williamson Robert F III | Director | Buy | 95.0 | +55,000 | 14.77% | ✗ | $75.9K |
| May 29, 2024 | May 30, 2024 | Williamson Robert F III | Director | Buy | 86.3 | +30,031 | 8.77% | ✗ | $40K |
| Apr 23, 2024 | Apr 24, 2024 | Austin Mark John | VP Finance/Prin Fin&Acct Offic | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 30, 2024 | Feb 1, 2024 | Williamson Robert F III | Director | Buy | 95.0 | +127,206 | 59.11% | ✗ | $90.7K |
| Jan 26, 2024 | Jan 30, 2024 | Williamson Robert F III | Director | Buy | 95.0 | +135,879 | 171.26% | ✗ | $78.5K |
| Jan 24, 2024 | Jan 26, 2024 | Puhlmann Markus | Chief Medical Officer | Buy | 95.0 | +280,000 | 25.56% | ✗ | $139.9K |
| Jan 24, 2024 | Jan 26, 2024 | Williamson Robert F III | Director | Buy | 91.3 | +51,996 | 190.16% | ✗ | $25.5K |
| Dec 21, 2023 | Dec 26, 2023 | Williamson Robert F III | Director | Buy | 90.0 | +3,663 | 15.47% | ✗ | $1.2K |
| Dec 18, 2023 | Dec 19, 2023 | Hunt Jonathan Robert | CFO | Buy | 91.3 | +125,000 | 65.20% | ✗ | $32.3K |
| Dec 18, 2023 | Dec 19, 2023 | Williamson Robert F III | Director | Buy | 90.0 | +23,680 | 100.00% | ✗ | $7K |
| Dec 15, 2023 | Dec 19, 2023 | Puhlmann Markus | Chief Medical Officer | Buy | 95.0 | +595,425 | 119.09% | ✗ | $188.7K |
| Dec 14, 2023 | Dec 18, 2023 | Woods Lori A | Director | Buy | 91.3 | +185,200 | 13.39% | ✗ | $50K |
| Dec 12, 2023 | Dec 14, 2023 | Puhlmann Markus | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 12, 2023 | Dec 14, 2023 | Spoor Johan M. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 12, 2023 | Dec 14, 2023 | Hunt Jonathan Robert | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 12, 2023 | Dec 14, 2023 | Morich Frank | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 12, 2023 | Dec 14, 2023 | Williamson Robert F III | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 12, 2023 | Dec 14, 2023 | HENSON HEIDI | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 12, 2023 | Dec 14, 2023 | Woods Lori A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 12, 2023 | Jun 14, 2023 | Streeter Jennifer | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 12, 2023 | Jun 14, 2023 | Austin Mark John | VP Finance/Prin Fin&Acct Offic | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2023 | Jun 6, 2023 | HENSON HEIDI | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2023 | HENSON HEIDI | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 13, 2023 | Apr 19, 2023 | Woods Lori A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 21, 2023 | Mar 17, 2023 | Williamson Robert F III | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 17, 2023 | Williamson Robert F III | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 21, 2023 | Feb 23, 2023 | Morich Frank | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 21, 2023 | Feb 23, 2023 | Woods Lori A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 21, 2023 | Feb 23, 2023 | McCormick Michael W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 13, 2023 | Morich Frank | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 13, 2023 | Puhlmann Markus | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 13, 2023 | Spoor Johan M. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 1, 2022 | Dec 5, 2022 | Hunt Jonathan Robert | CFO | Buy | 91.3 | +85,404 | 80.34% | ✗ | $32.5K |
| Nov 15, 2022 | Nov 17, 2022 | Woods Lori A | CEO | Buy | 86.3 | +100,000 | 9.13% | ✗ | $33.5K |
| Aug 18, 2022 | Sep 22, 2022 | Streeter Jennifer | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 18, 2022 | Aug 19, 2022 | Streeter Jennifer | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 9, 2022 | Aug 11, 2022 | Austin Mark John | VP Finance/Prin Fin&Acct Offic | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 5, 2022 | Aug 10, 2022 | Streeter Jennifer | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 21, 2022 | Aug 1, 2022 | Cavanagh William | Chief R&D Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 21, 2022 | Jul 29, 2022 | McCormick Michael W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 21, 2022 | Jul 28, 2022 | Hunt Jonathan Robert | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 21, 2022 | Jul 28, 2022 | Woods Lori A | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 21, 2022 | Jul 28, 2022 | Streeter Jennifer | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 21, 2022 | Jul 28, 2022 | Vitale Philip J | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 21, 2022 | Jul 28, 2022 | Hoffmann Alan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 8, 2022 | Jun 9, 2022 | Austin Mark John | VP Finance/Prin Fin&Acct Offic | Buy | 90.0 | +18,800 | 53.36% | ✗ | $5.4K |
| Jun 7, 2022 | Jun 9, 2022 | Woods Lori A | CEO | Buy | 86.3 | +75,000 | 7.35% | ✗ | $22.2K |
| Jun 7, 2022 | Jun 9, 2022 | Hunt Jonathan Robert | CFO | Buy | 91.3 | +39,000 | 57.94% | ✗ | $11.2K |
| Nov 23, 2021 | Nov 24, 2021 | Woods Lori A | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2021 | Jul 6, 2021 | Cavanagh William | Chief R&D Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2021 | Jul 6, 2021 | Austin Mark John | Controller/Prin Fin&Acct Offic | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2021 | Jul 6, 2021 | Streeter Jennifer | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |